review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Carol M Troy | |
Ying Y Jean | |||
P2860 | cites work | Activated caspase-3 expression in Alzheimer's and aged control brain: correlation with Alzheimer pathology. | Q48913487 |
Overlapping cleavage motif selectivity of caspases: implications for analysis of apoptotic pathways. | Q50659185 | ||
In situ trapping of activated initiator caspases reveals a role for caspase-2 in heat shock-induced apoptosis. | Q50744961 | ||
Alice in caspase land. A phylogenetic analysis of caspases from worm to man | Q59661526 | ||
Caspase-2 mediates neuronal cell death induced by beta-amyloid | Q73419649 | ||
DNA damage- and stress-induced apoptosis occurs independently of PIDD | Q84164825 | ||
Combined suppression of CASP2 and CASP6 protects retinal ganglion cells from apoptosis and promotes axon regeneration through CNTF-mediated JAK/STAT signalling | Q33654204 | ||
Caspase-3 activation via mitochondria is required for long-term depression and AMPA receptor internalization. | Q34019051 | ||
Caspase gene expression in the brain as a function of the clinical progression of Alzheimer disease | Q34183217 | ||
Middle cerebral artery occlusion model in rodents: methods and potential pitfalls | Q34558344 | ||
Human caspases: activation, specificity, and regulation | Q34608215 | ||
Caspase activation precedes and leads to tangles | Q34965124 | ||
Caspase-2 is required for dendritic spine and behavioural alterations in J20 APP transgenic mice. | Q35430964 | ||
Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death. | Q35788051 | ||
Neuronal caspase 2 activity and function requires RAIDD, but not PIDD | Q36002031 | ||
Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer's disease | Q36943100 | ||
The inflammasome: a danger sensing complex triggering innate immunity | Q36989115 | ||
IAPs: what's in a name? | Q37148694 | ||
Metabolic regulation of oocyte cell death through the CaMKII-mediated phosphorylation of caspase-2. | Q37459556 | ||
Caspase-2 is essential for c-Jun transcriptional activation and Bim induction in neuron death. | Q37527207 | ||
The contrasting roles of ICE family proteases and interleukin-1beta in apoptosis induced by trophic factor withdrawal and by copper/zinc superoxide dismutase down-regulation | Q37594604 | ||
The NLRP3 inflammasome: a sensor for metabolic danger? | Q37675505 | ||
Regulation of caspases in the nervous system implications for functions in health and disease | Q37829034 | ||
FLIP: a flop for execution signals | Q38025248 | ||
The NLRP3 inflammasome in Alzheimer's disease | Q38107892 | ||
Inhibitor of Apoptosis (IAP) proteins in hematological malignancies: molecular mechanisms and therapeutic opportunities | Q38184343 | ||
Alzheimer's disease genetics: from the bench to the clinic | Q38225911 | ||
Death in the balance: alternative participation of the caspase-2 and -9 pathways in neuronal death induced by nerve growth factor deprivation. | Q38299296 | ||
Caspases-2 and -8 are involved in the presenilin1/gamma-secretase-dependent cleavage of amyloid precursor protein after the induction of apoptosis | Q39741851 | ||
Caspase-4 is partially cleaved by calpain via the impairment of Ca2+ homeostasis under the ER stress | Q39772134 | ||
The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases | Q40341729 | ||
A potential role for apoptosis in neurodegeneration and Alzheimer's disease | Q40437117 | ||
Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society | Q40880223 | ||
A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor | Q40890347 | ||
Intranasal delivery of caspase-9 inhibitor reduces caspase-6-dependent axon/neuron loss and improves neurological function after stroke | Q42023698 | ||
Caspase activity is essential for long-term potentiation | Q44569667 | ||
NLRP3 polymorphisms are associated with late-onset Alzheimer's disease in Han Chinese | Q45271670 | ||
Caspase-3 in the central nervous system: beyond apoptosis | Q45289299 | ||
Caspase enzymology and activation mechanisms | Q46609304 | ||
Local caspase activity directs engulfment of dendrites during pruning. | Q47071864 | ||
Caspase-6 role in apoptosis of human neurons, amyloidogenesis, and Alzheimer's disease | Q48142435 | ||
Role of caspase-12 in amyloid beta-peptide-induced toxicity in organotypic hippocampal slices cultured for long periods. | Q48191886 | ||
Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain. | Q48418085 | ||
Coordinated expression of caspase 8, 3 and 7 mRNA in temporal cortex of Alzheimer disease: relationship to formic acid extractable abeta42 levels. | Q48497671 | ||
Activation of caspase-8 in the Alzheimer's disease brain. | Q48691018 | ||
An English translation of Alzheimer's 1907 paper, "Uber eine eigenartige Erkankung der Hirnrinde". | Q48903618 | ||
Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta | Q22011091 | ||
The inflammasomes | Q24304087 | ||
Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease | Q24312611 | ||
Caspase-2 primes cancer cells for TRAIL-mediated apoptosis by processing procaspase-8 | Q24337211 | ||
Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Abeta-induced cell death | Q24338605 | ||
Caspase-2 activation in the absence of PIDDosome formation | Q24641934 | ||
Caspase 3 attenuates XIAP (X-linked inhibitor of apoptosis protein)-mediated inhibition of caspase 9 | Q24669658 | ||
Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family | Q24670396 | ||
Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition | Q28115131 | ||
Caspase-14: analysis of gene structure and mRNA expression during keratinocyte differentiation | Q28142885 | ||
A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes | Q28237565 | ||
The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme | Q28256420 | ||
Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3 | Q28645710 | ||
Dynamic role of postsynaptic caspase-3 and BIRC4 in zebra finch song-response habituation | Q28762978 | ||
The NALP3 inflammasome is involved in the innate immune response to amyloid-beta | Q29615595 | ||
Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9 | Q29618617 | ||
NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production? | Q29619524 | ||
Caspase-3 activation as a bifurcation point between plasticity and cell death. | Q30446892 | ||
Revision of the criteria for Alzheimer’s disease: A symposium | Q30452902 | ||
Characterization of cytoplasmic caspase-2 activation by induced proximity. | Q30490693 | ||
P433 | issue | 1 | |
P304 | page(s) | 42-48 | |
P577 | publication date | 2015-01-01 | |
P1433 | published in | Neurotherapeutics | Q15716631 |
P1476 | title | Caspases: therapeutic targets in neurologic disease | |
P478 | volume | 12 |
Q48332447 | Caspase-3-dependent cleavage of Akt modulates tau phosphorylation via GSK3β kinase: implications for Alzheimer's disease |
Q42371397 | Caspase-8, association with Alzheimer's Disease and functional analysis of rare variants |
Q28078362 | Clearing the corpses: regulatory mechanisms, novel tools, and therapeutic potential of harnessing microglial phagocytosis in the diseased brain |
Q41862916 | Inhibition of cerebral ischemia/reperfusion injury-induced apoptosis: nicotiflorin and JAK2/STAT3 pathway. |
Q37015713 | MiR-34a and miR-203 Inhibit Survivin Expression to Control Cell Proliferation and Survival in Human Osteosarcoma Cells |
Q37396889 | Mutations in CRADD Result in Reduced Caspase-2-Mediated Neuronal Apoptosis and Cause Megalencephaly with a Rare Lissencephaly Variant |
Q47441615 | Non-apoptotic Caspase regulation of stem cell properties |
Q26766250 | Survivin and Tumorigenesis: Molecular Mechanisms and Therapeutic Strategies |
Search more.